Status:

RECRUITING

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)

Lead Sponsor:

DexCom, Inc.

Conditions:

Diabetes

Eligibility:

All Genders

2+ years

Brief Summary

"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"

Detailed Description

"The Dexcom Global Registry is a non-randomized, open-label, multi-center registry with the goal of collecting Dexcom CGM System data in a real world setting.The registry study involves retrospective ...

Eligibility Criteria

Inclusion

  • Meets Dexcom CGM System Indications for Use (IFU) per approved commercial labeling
  • Has at least one HbA1C (Hemoglobin a1c) measurement within three (3) months prior to the Dexcom CGM System use start date that is at least three (3) months after any prior CGM use
  • Subject is willing and able to use Dexcom CGM System according to approved product labeling
  • Subject is willing and able to complete applicable patient reported outcome assessments/ surveys
  • Subject is willing and able to comply with the protocol
  • Subject is willing and able to comply with provider requirements for at least two provider encounters per year according to applicable clinical practice guidelines
  • Subject or the subject's legally authorized representative must provide written informed consent prior to any study-related data collection or be enrolled under an IRB/EC approved waiver of consent

Exclusion

  • Is contraindicated for a Dexcom CGM System per approved commercial labeling
  • In the Investigator's opinion, the subject is not considered to be a suitable candidate

Key Trial Info

Start Date :

February 28 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2028

Estimated Enrollment :

5000 Patients enrolled

Trial Details

Trial ID

NCT06483945

Start Date

February 28 2024

End Date

June 30 2028

Last Update

July 3 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Institute of Endocrinology Diabetes, Health & Hormones

Stockbridge, Georgia, United States, 30281

2

Palm Research Center

Las Vegas, Nevada, United States, 89148